We are live on ! Find out more
MDXG icon

MiMedx Group

202 hedge funds and large institutions have $721M invested in MiMedx Group in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $728K

15% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 26

2% more funds holding

Funds holding: 199202 (+3)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

5% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 62

8% less capital invested

Capital invested by funds: $786M → $721M (-$65.8M)

13.36% less ownership

Funds ownership: 77.05%63.68% (-13%)

Holders
202
Holders Change
+3
Holders Change %
+1.51%
% of All Funds
2.91%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
30
Increased
59
Reduced
62
Closed
26
Calls
$1.76M
Puts
$728K
Net Calls
+$1.03M
Net Calls Change
-$459K
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$217M
BlackRock
2
BlackRock
New York
$70.6M -$2.93M -364,595 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$45.6M -$5.18M -644,530 -10%
State Street
4
State Street
Massachusetts
$38.1M +$6.86M +853,250 +21%
PCMI
5
Paradigm Capital Management Inc
New York
$30.1M +$3.84M +478,100 +14%
TI
6
Trigran Investments
Illinois
$25.1M +$26.2M +3,256,949 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$20.2M +$665K +82,784 +3%
CC
8
Cannell Capital
Wyoming
$18.7M -$382K -47,475 -2%
Morgan Stanley
9
Morgan Stanley
New York
$14.8M -$10M -1,246,618 -39%
Renaissance Technologies
10
Renaissance Technologies
New York
$13.5M +$4.06M +504,800 +40%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$9.75M +$1.5M +186,822 +17%
Charles Schwab
12
Charles Schwab
California
$9.02M +$299K +37,200 +3%
RB
13
Richmond Brothers
Michigan
$8.45M -$2.47M -307,336 -22%
Northern Trust
14
Northern Trust
Illinois
$8.1M -$196K -24,430 -2%
Prudential Financial
15
Prudential Financial
New Jersey
$7.98M +$786K +97,800 +10%
Arrowstreet Capital
16
Arrowstreet Capital
Massachusetts
$7.16M +$60.7K +7,554 +0.8%
Federated Hermes
17
Federated Hermes
Pennsylvania
$7.02M +$836K +103,991 +13%
RA
18
Royce & Associates
New York
$6.9M +$274K +34,122 +4%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$6.77M +$5.39M +670,657 +321%
Two Sigma Investments
20
Two Sigma Investments
New York
$5.8M +$1.07M +133,677 +22%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$5.79M +$244K +30,300 +4%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$5.66M +$2.39M +297,543 +68%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$4.83M +$1.61M +200,381 +47%
Goldman Sachs
24
Goldman Sachs
New York
$4.81M +$1.12M +139,650 +29%
PAIM
25
Punch & Associates Investment Management
Minnesota
$4.81M +$5.02M +624,180 New

MDXG Hedge Fund Activity: Q1 2024 in Review

202 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q1 2024, worth a combined $721M — down 8.4% from $786M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new MDXG positions and 26 closed out — a net gain of 4 holders — while 59 added to existing stakes and 62 trimmed.

The largest buyer was Trigran Investments, opening a new position worth an estimated $26.2M. The largest seller was Morgan Stanley, cutting an estimated $10M.

  • 202 institutional investors held MiMedx Group (MDXG) as of Q1 2024, up from 199 in Q4 2023.
  • Funds reported $721M of MiMedx Group stock for Q1 2024, down 8.4% quarter-over-quarter.
  • 30 funds opened new MiMedx Group positions in Q1 2024 and 26 closed out, a net change of +4 holders.
  • The largest MiMedx Group buyer in Q1 2024 was Trigran Investments, an estimated $26.2M added.
  • The largest MiMedx Group seller in Q1 2024 was Morgan Stanley, an estimated $10M sold.

Based on aggregated 13F filings for Q1 2024.